O	0	12	Longitudinal
O	13	19	impact
O	20	22	of
B-intervention	23	27	yoga
O	28	30	on
B-condition	31	43	chemotherapy
I-condition	43	44	-
I-condition	44	51	related
I-condition	52	61	cognitive
I-condition	62	72	impairment
O	73	76	and
O	77	84	quality
O	85	87	of
O	88	92	life
O	93	95	in
O	96	101	women
O	102	106	with
O	107	112	early
O	113	118	stage
O	119	125	breast
O	126	132	cancer
O	132	133	:
O	134	135	a
O	136	140	case
O	141	147	series
O	147	148	.

O	149	157	Adjuvant
O	158	170	chemotherapy
O	171	174	for
O	175	180	women
O	181	185	with
O	186	192	breast
O	193	199	cancer
O	200	203	has
O	204	217	significantly
O	218	226	improved
O	227	230	the
O	231	235	cure
O	236	240	rate
O	240	241	;
O	242	249	however
O	249	250	,
O	251	253	it
O	254	257	has
O	258	262	been
O	263	273	associated
O	274	278	with
O	279	291	chemotherapy
O	291	292	-
O	292	299	related
O	300	309	cognitive
O	310	316	impact
O	317	318	(
O	318	322	CRCI
O	322	323	)
O	323	324	.

O	325	328	The
O	329	339	literature
O	340	348	provides
O	349	360	preliminary
O	361	368	support
O	369	372	for
O	373	376	the
O	377	388	feasibility
O	389	392	and
O	393	401	efficacy
O	402	404	of
O	405	409	yoga
O	410	423	interventions
O	424	427	for
O	428	431	the
O	432	439	general
O	440	446	cancer
O	447	457	population
O	457	458	,
O	459	466	however
O	466	467	,
O	468	478	controlled
O	479	485	trials
O	486	489	are
O	490	496	scarce
O	497	500	and
O	501	503	no
O	504	511	studies
O	512	516	have
O	517	525	examined
O	526	529	the
O	530	536	effect
O	537	539	of
O	540	544	yoga
O	545	547	on
O	548	557	cognition
O	558	561	for
O	562	567	women
O	568	572	with
O	573	579	breast
O	580	586	cancer
O	587	593	during
O	594	606	chemotherapy
O	606	607	.

O	608	612	This
O	613	617	case
O	618	624	series
O	625	629	aims
O	630	632	to
O	633	641	identify
O	642	645	the
O	646	652	impact
O	653	655	of
O	656	660	yoga
O	661	663	on
O	664	672	measures
O	673	675	of
O	676	685	cognition
O	685	686	,
O	687	697	functional
O	698	706	outcomes
O	706	707	,
O	708	711	and
O	712	719	quality
O	720	722	of
O	723	727	life
O	728	729	(
O	729	732	QOL
O	732	733	)
O	734	737	for
O	738	744	breast
O	745	751	cancer
O	752	761	survivors
O	762	763	(
O	763	766	BCS
O	766	767	)
O	767	768	.

B-total-participants	769	773	Four
B-eligibility	774	779	women
I-eligibility	780	784	with
I-eligibility	785	786	a
I-eligibility	787	796	diagnosis
I-eligibility	797	799	of
I-eligibility	800	805	early
I-eligibility	805	806	-
I-eligibility	806	811	stage
I-eligibility	812	818	breast
I-eligibility	819	825	cancer
I-eligibility	826	831	prior
I-eligibility	832	834	to
I-eligibility	835	847	chemotherapy
I-eligibility	848	857	treatment
O	858	862	were
O	863	875	administered
O	876	879	the
O	880	889	following
O	890	901	physiologic
O	902	910	measures
O	911	913	at
O	914	922	baseline
O	922	923	,
O	924	925	6
O	925	926	,
O	927	930	and
O	931	933	12
O	934	939	weeks
O	940	946	during
O	947	959	chemotherapy
O	959	960	,
O	961	964	and
O	965	967	at
O	968	971	one
O	972	975	and
O	976	981	three
O	982	988	months
O	989	994	after
O	995	998	the
O	999	1009	conclusion
O	1010	1012	of
O	1013	1016	the
O	1017	1022	study
O	1022	1023	:
O	1024	1034	Functional
O	1035	1040	Reach
O	1041	1045	test
O	1046	1047	(
O	1047	1054	balance
O	1054	1055	)
O	1056	1059	and
O	1060	1063	Sit
O	1064	1067	and
O	1068	1073	Reach
O	1074	1078	test
O	1079	1080	(
O	1080	1091	flexibility
O	1091	1092	)
O	1092	1093	,
O	1094	1097	and
O	1098	1101	QOL
O	1101	1102	,
O	1103	1107	POMS
O	1108	1109	(
O	1109	1113	Mood
O	1113	1114	)
O	1115	1118	and
O	1119	1123	FACT
O	1123	1124	-
O	1124	1125	B
O	1126	1127	(
O	1127	1130	QOL
O	1130	1131	)
O	1131	1132	,
O	1133	1135	at
O	1136	1144	baseline
O	1144	1145	.

O	1146	1153	Primary
O	1154	1162	outcomes
O	1163	1165	of
B-outcome-Measure	1166	1175	cognition
O	1176	1180	were
O	1181	1189	measured
O	1190	1194	with
O	1195	1198	the
O	1199	1208	Perceived
O	1209	1218	Cognition
O	1219	1232	Questionnaire
O	1233	1234	(
O	1234	1237	PCQ
O	1237	1238	)
O	1239	1242	and
O	1243	1251	CogState
O	1251	1252	,
O	1253	1254	a
O	1255	1267	computerized
O	1268	1279	measurement
O	1280	1282	of
O	1283	1292	cognition
O	1292	1293	.

O	1294	1299	Women
O	1300	1308	attended
O	1309	1311	an
O	1312	1319	Iyengar
O	1319	1320	-
O	1320	1328	inspired
O	1329	1333	yoga
O	1334	1341	program
O	1342	1347	twice
O	1348	1349	a
O	1350	1354	week
O	1355	1358	for
O	1359	1361	12
O	1362	1367	weeks
O	1367	1368	.

O	1369	1380	Qualitative
O	1381	1395	questionnaires
O	1396	1400	were
O	1401	1413	administered
O	1414	1419	after
O	1420	1423	the
O	1424	1434	completion
O	1435	1437	of
O	1438	1441	the
O	1442	1447	study
O	1448	1450	to
O	1451	1460	determine
O	1461	1470	perceived
O	1471	1479	benefits
O	1480	1483	and
O	1484	1494	challenges
O	1495	1497	of
O	1498	1501	the
O	1502	1506	yoga
O	1507	1514	program
O	1514	1515	.

B-total-participants	1516	1520	Four
O	1521	1526	women
O	1527	1531	with
O	1532	1537	Stage
O	1538	1540	II
O	1541	1547	breast
O	1548	1554	cancer
O	1555	1561	ranged
O	1562	1564	in
O	1565	1568	age
O	1569	1573	from
B-age	1574	1576	44
I-age	1576	1577	-
I-age	1577	1579	65
I-age	1580	1585	years
O	1585	1586	.

O	1587	1595	CogState
O	1596	1608	computerized
O	1609	1616	testing
O	1617	1623	showed
B-outcome	1624	1631	changes
I-outcome	1632	1634	in
I-outcome	1635	1642	varying
I-outcome	1643	1650	domains
I-outcome	1651	1653	of
I-outcome	1654	1663	cognition
O	1664	1671	through
O	1672	1681	treatment
O	1682	1685	and
O	1686	1692	follow
O	1692	1693	-
O	1693	1695	up
O	1695	1696	.

B-outcome	1697	1705	Improved
I-outcome	1706	1713	balance
I-outcome	1713	1714	,
I-outcome	1715	1726	flexibility
I-outcome	1726	1727	,
I-outcome	1728	1731	and
I-outcome	1732	1735	QOL
O	1736	1740	were
O	1741	1745	also
O	1746	1751	noted
O	1752	1756	over
O	1757	1761	time
O	1761	1762	.

B-outcome	1763	1765	No
I-outcome	1766	1773	adverse
I-outcome	1774	1780	events
O	1781	1785	were
O	1786	1794	observed
O	1794	1795	.

O	1796	1804	Analysis
O	1805	1807	of
O	1808	1819	qualitative
O	1820	1824	data
O	1825	1833	revealed
O	1834	1837	the
O	1838	1842	yoga
O	1843	1850	classes
O	1851	1855	were
O	1856	1863	helpful
O	1864	1867	and
O	1868	1876	subjects
O	1877	1886	continued
O	1887	1890	the
O	1891	1899	practice
O	1900	1908	elements
O	1909	1911	of
O	1912	1916	yoga
O	1917	1926	including
O	1927	1937	relaxation
O	1937	1938	,
O	1939	1948	breathing
O	1948	1949	,
O	1950	1953	and
O	1954	1964	stretching
O	1964	1965	.

O	1966	1969	The
O	1970	1974	most
O	1975	1986	challenging
O	1987	1993	aspect
O	1994	1996	of
O	1997	2000	the
O	2001	2006	study
O	2007	2010	was
O	2011	2019	physical
O	2020	2031	limitations
O	2032	2035	due
O	2036	2038	to
O	2039	2046	various
O	2047	2054	medical
O	2055	2068	complications
O	2069	2072	and
O	2073	2081	included
O	2082	2089	fatigue
O	2089	2090	,
O	2091	2100	decreased
O	2101	2106	range
O	2107	2109	of
O	2110	2116	motion
O	2116	2117	,
O	2118	2121	and
O	2122	2126	pain
O	2126	2127	.

O	2128	2132	This
O	2133	2137	case
O	2138	2144	series
O	2145	2153	suggests
O	2154	2158	that
O	2159	2163	yoga
O	2164	2167	may
O	2168	2174	impact
O	2175	2182	various
O	2183	2190	aspects
O	2191	2193	of
O	2194	2203	cognition
O	2204	2210	during
O	2211	2214	and
O	2215	2220	after
O	2221	2233	chemotherapy
O	2234	2248	administration
O	2249	2251	as
O	2252	2257	noted
O	2258	2265	through
O	2266	2278	quantitative
O	2279	2287	measures
O	2287	2288	.

O	2289	2294	Women
O	2295	2303	describe
O	2304	2308	yoga
O	2309	2311	as
O	2312	2321	improving
O	2322	2329	various
O	2330	2337	domains
O	2338	2340	of
O	2341	2344	QOL
O	2345	2352	through
O	2353	2356	the
O	2357	2366	treatment
O	2367	2377	trajectory
O	2377	2378	.

O	2379	2383	This
O	2384	2388	mind
O	2388	2389	-
O	2389	2393	body
O	2394	2406	intervention
O	2407	2410	may
O	2411	2416	stave
O	2417	2420	off
O	2421	2425	CRCI
O	2425	2426	;
O	2427	2434	however
O	2434	2435	,
O	2436	2443	further
O	2444	2457	investigation
O	2458	2460	is
O	2461	2467	needed
O	2468	2471	for
O	2472	2482	additional
O	2483	2493	randomized
O	2494	2504	controlled
O	2505	2511	trials
O	2512	2514	on
O	2515	2518	the
O	2519	2526	effects
O	2527	2529	of
O	2530	2534	yoga
O	2535	2537	on
O	2538	2547	cognition
O	2548	2551	for
O	2552	2557	women
O	2558	2562	with
O	2563	2569	breast
O	2570	2576	cancer
O	2577	2587	undergoing
O	2588	2596	adjuvant
O	2597	2609	chemotherapy
O	2610	2619	treatment
O	2619	2620	.
